Open navigation
Search

CMS advises BC Partners on sale of synlab Group to Cinven

29 Jun 2015 Germany 4 min read

Stuttgart – Private equity investor Cinven has acquired a majority stake in the Augsburg-based synlab Group. With operations throughout Europe, synlab provides human and veterinary lab services as well as environmental analysis. The vendor is BC Partners, also a private equity investor. Cinven recently acquired French lab service provider Labco.

Several law firms in the CMS network worked together as part of an international team to advise BC Partners on the sale of the synlab Group to Cinven. Private equity firm BC Partners has been advised by CMS Hasche Sigle for many years. The team led by Dr Udo Simmat advised BC Partners back in 2009 on its investment in lab service providers synlab and FutureLAB, in conjunction with several CMS firms. The Group was subsequently restructured under corporate law with support from CMS and significantly enlarged by way of acquisitions.

BC Partners Limited is a European private equity firm headquartered in London, with offices in Hamburg, Paris, Milan, Geneva and New York. Synlab has branches in 23 European countries. In 2014, the company generated sales of around EUR 756 million and had more than 7,000 employees.

CMS Hasche Sigle, Germany

Dr Udo Simmat
Dr Tobias Schneider
Dr Jacob Siebert
Dr Christoph Lächler
Dr Johannes Braun, all Private Equity, M&A
Patrick Schultz, M&A
Dr Gerald Gräfe, Commercial

CMS DeBacker, Belgium

Arnaud Van Oekel, Lead Partner
David Prync, both Corporate, M&A

CMS Adonnino Ascoli & Cavasola Scamoni, Italy

Pietro Cavasola, Lead Partner
Rosida Carpagnano
Serena Carroli
Giacomo Cavasola, all Corporate, M&A

CMS Reich-Rohrwig Hainz, Austria

Dr Günther Hanslik, Lead Partner
Andreas Göller
Ioanna Ovadias, all Corporate, M&A
Dr Andrea Potz, Employment

CMS von Erlach Poncet AG, Switzerland

Alain Raemy, Lead Partner
Andrea Ferchl
Sophie Bühler, all Corporate, M&A

CMS Cameron McKenna, Hungary

Dr Zoltan Poronyi, Corporate, M&A
Peter Deak
Dr Veronika Kovács, both Commercial, TMT, Lifesciences, IP

CMS Danişmanlik Hizmetleri Avukatlik Ortakliği, Turkiye

Dr Döne Yalçın
Özgün Poyraz, both Corporate, M&A

Press Contact
[email protected]

Attachment
PDF
216.8 kB
CMS advises BC Partners on sale of synlab Group to Cinven
Back to top Back to top
Warning: Fraudulent emails and messages
Opens in new window